National Comprehensive Cancer Network



About NCCN

Central Nervous System Cancers Panel - Disclosures as of 11/26/2013

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Mario Ammirati, MD, MBA

None

None

None

None

11/21/2014

Henry Brem, MD

None

None

None

None

11/4/2014

Paul Brown, MD

National Cancer Institute;
National Cancer Institute

Novocure

None

None

9/10/2014

Nicholas Butowski, MD

None

Roche Laboratories, Inc.

None

None

9/8/2014

Marc C. Chamberlain, MD

NCCN Funded Bendamustine trial for Recurrent High-Grade Gliomas

PharmacoKinesis Advisory Board;
Roche Laboratories, Inc.;
Sigma-Tau Pharmaceuticals, Inc.

None

None

10/15/2014

Lisa M. DeAngelis, MD

None

None

None

None

1/8/2014

Robert A. Fenstermaker, MD

None

None

None

None

10/16/2014

Allan Friedman, MD

None

None

None

None

9/26/2012

Lauren Gallagher, RPh, PhD

None

None

None

None

12/8/2014

Mark R. Gilbert, MD

RTOG Trial

Abbott Laboratories;
Genentech, Inc.;
Merck & Co., Inc.;
EMD Serono

None

None

8/18/2013

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

9/16/2014

Jona Hattangadi-Gluth, MD

None

None

None

None

9/3/2014

Deneen Hesser, MSHSA, RN, OCN

None

None

None

National Cancer Institute

11/8/2013

Maria Ho, PhD

None

None

None

None

7/10/2014

Matthias Holdhoff, MD, PhD

None

None

None

None

11/2/2014

Larry Junck, MD

None

None

None

None

9/16/2014

Ronald Lawson, MD, FACP

None

None

None

None

9/10/2014

Jay S. Loeffler, MD

None

None

None

None

11/3/2014

Joan S. McClure, MS

None

None

None

None

12/8/2014

Nicole McMillian, MS

None

None

None

None

10/8/2014

Paul L. Moots, MD

None

None

None

None

11/1/2014

Maciej M. Mrugala, MD, PhD, MPH

None

Enzon Pharmaceuticals;
Schering-Plough Corporation

None

None

10/31/2014

Louis Burt Nabors, MD

AstraZeneca Pharmaceuticals LP;
Boehringer Ingelheim GmbH;
Eli Lilly and Company;
Genentech, Inc.;
GlaxoSmithKline;
ImClone Systems Incorporated;
Merck KGaA;
Transmolecular

Merck KGaA

None

None

10/30/2014

Herbert B. Newton, MD

None

Genentech, Inc.

None

None

10/30/2014

Jana Portnow, MD

None

None

None

None

10/15/2014

Jeffrey J. Raizer, MD

None

Enzon Pharmaceuticals;
Genentech, Inc.;
Genentech, Inc.;
Genentech, Inc.;
Genentech, Inc.;
Merck & Co., Inc.;
Novartis Pharmaceuticals Corporation;
Novartis Pharmaceuticals Corporation;
Agenus;
EMD Serano

None

None

12/8/2014

Lawrence Recht, MD

None

Genentech, Inc.

None

None

10/30/2014

Nicole Shonka, MD

None

Novocure advisory board

None

None

9/18/2014

Dennis C. Shrieve, MD, PhD

None

None

None

None

11/26/2014

Allen K. Sills, MD

None

None

None

None

10/7/2014

Lode J. Swinnen, MB, ChB

Abbott Laboratories

None

None

None

10/10/2014

Nam Tran, MD, PhD

None

None

None

None

11/24/2014

David Tran, MD, PhD

Novocure

Novocure

None

None

12/9/2014

Sarika Trikha, PharmD

None

None

None

None

11/11/2014

Frank D. Vrionis, MD, MPH, PhD

None

Florida Board of Medicine;
Southeastern Brain Tumor Association

None

Orthofix

9/23/2014

Patrick Yung Wen, MD

None

Genentech, Inc.;
Genentech, Inc.;
GlaxoSmithKline;
Merck & Co., Inc.;
Merck & Co., Inc.;
Novartis Pharmaceuticals Corporation;
EMD Serono

None

Amgen Inc.;
AstraZeneca Pharmaceuticals LP;
Boehringer Ingelheim GmbH;
Eisai Inc.;
Exelixis Inc.;
Genentech, Inc.;
MedImmune Inc.;
Merck & Co., Inc.;
Novartis Pharmaceuticals Corporation;
Geron;
Vascular Biogenics;
sanofi-aventis U.S.

12/17/2014